Alto Neuroscience ANRO Issuance of warrants
Issuance of warrants at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's issuance of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's issuance of warrants?
- Alto Neuroscience (ANRO) reported issuance of warrants of $0 in Q1 2026.
- How has Alto Neuroscience's issuance of warrants changed year-over-year?
- Alto Neuroscience's issuance of warrants decreased by 100.0% year-over-year, from $524K to $0.
- What does issuance of warrants mean?
- Represents the issuance of warrants, which are equity-linked instruments often used as sweeteners in financing deals or as compensation. This metric tracks the dilution impact and the non-cash equity component of the company's capital structure. It is critical for investors analyzing potential future share dilution and the cost of capital.